Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: A pilot study

Blood

Volumn 96, Issue 7, 2000, Pages 2426-2431

  Greinix, H T ^a   Volc Platzer, B ^a   Kalhs, P ^a   Fischer, G ^a   Rosenmayr, A ^a   Keil, F ^a   Honigsmann, H ^a   Knobler, R M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXSALEN; STEROID;

ADULT; ARTICLE; BLOOD CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; MALE; MONONUCLEAR CELL; MORTALITY; PHOTOCHEMOTHERAPY; PILOT STUDY; PRIORITY JOURNAL; PUVA; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION;

EID: 0034307671     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.7.2426     Document Type: Article

References (36)

1. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft-versus-host disease after marrow transplantation for leukemia
2. Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies
3. A randomized trial comparing use of cyclosporin and methotrexate for graft-versus-host disease prophylaxis in bone marrow transplant recipients with haematological malignancies
4. IBMTR severity index for grading acute graft-versus-host disease: Retrospective comparison with Glucksberg grade
5. Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: An analysis of clinical risk features and outcome
6. Acute graft-versus-host disease: Analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate
7. The cytokine modulation of acute graft-versus-host disease
8. Treatment of moderate and severe acute GVHD after allogeneic bone marrow transplantation
9. Management of acute graft-versus-host disease
10. Treatment of graft-versus-host disease in human allogeneic marrow graft recipients: A randomized trial comparing antithymocyte globulin and corticosteroids
11. Extracorporeal photochemotherapy
12. Photopheresis for the prevention of rejection in cardiac transplantation
13. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease
14. Extracorporeal photochemotherapy in the treatment of severe graft-versus-host disease
15. Extracorporeal photochemotherapy: A scientific overview
16. Treatment of graft-versus-host disease by extracorporeal photochemotherapy
17. Extracorporeal photopheresis in the treatment of acute graft-versus-host disease
18. Treatment of graft-versus-host disease with photopheresis
19. Chronic graft-versus-host disease in 52 patients: Adverse natural course and successful treatment with combination immunosuppression
20. Histopathology of graft-versus-host reaction (GVHR) in human recipients from HLA-matched sibling donors
21. Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: A multicenter randomized trial from the Italian Group for Bone Marrow Transplantation
22. Treatment of human acute graft-versus-host disease with antithymocyte globuline and cyclosporine with or without methylprednisolone
23. Prevention and treatment of acute GvHD-new modalities
24. Treatment of acute graft-versus-host disease with humanized anti Tac: An antibody that binds to the interleukin-2 receptor
25. Treatment of steroid resistant graft-versus-host disease after allogeneic bone marrow transplantation with anti-CD3/TCR monoclonal antibodies
26. New and experimental therapies for treating graft-versus-host disease
27. A retrospective analysis of therapy for acute graft-versus-host disease: Secondary treatment
28. Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease
29. A phase II study of BTI-322, a monoclonal anti-CD2 antibody, for treatment of steroid-resistant acute graft-versus-host disease
30. Acute graft-versus-host disease after allogeneic blood stem cell transplantation: Factors determining treatment failure and survival
31. Photopheresis treatment enhances CD95 (FAS) expression in circulating lymphocytes of patients with systemic sclerosis and induces apoptosis
32. Apoptosis induction by ultraviolet light A and photochemotherapy in cutaneous T-cell lymphoma: Relevance to mechanism of therapeutic action
33. Enhancement of major histocompatibility class I protein synthesis by DNA damage in cultured human fibroblasts and keratinocytes
34. + T cells
35. Specific suppression of lupus-like graft-versus-host disease using extracorporeal photochemical attenuation of effector lymphocytes
36. Inhibition of autoimmune disease in a murine model of systemic lupus erythematosus induced by exposure to syngeneic photoinactivated lymphocytes